CD Biosynsis is dedicated to the construction of engineered strains with high arginine production by modifying microbial strains through synthetic biology techniques based on the metabolic pathways and regulatory mechanisms of arginine.
Arginine is a semi-essential amino acid that is synthesized in most microorganisms and is widely used in the food and pharmaceutical industries due to its special physiological and biochemical functions. Arginine metabolism has no branching pathways and the end product arginine is synthesized directly from the intermediate metabolite glutamate, which is catalyzed by 7-8 enzymes. Currently, arginine is mainly synthesized by microbial fermentation. The development of synthetic biology technology has provided an effective solution for the large-scale production of arginine.
Figure 1. Reticulated view of acetylation steps in the arginine biosynthesis pathway. (Xu Y, et al., 2007)
Based on synthetic biology strategies, we are able to optimize the microbial production process of arginine and maximize the potential of the L-arginine biosynthesis pathway.
We can regulate the expression of genes in the arginine metabolic pathway through genetic engineering techniques, thus improving the stability of the strain.
We can use metabolic engineering technology to construct arginine engineered bacteria.
We can synthesize arginine using microbial fermentation technology. The following table shows the arginine production strains for which we provide microbial chassis development services. Please contact us directly if you have other chassis of interest for arginine production.
|Corynebacterium glutamicum||Escherichia coli||Bacillus subtilis||Saccharomyces cerevisiae||Bacillus licheniformis|
With the elucidation of feedback inhibition and deterrence in the arginine biosynthetic pathway, metabolic engineering breeding has become a new breeding alternative to conventional breeding. We focus on the following metabolic engineering modification strategies.
In order to reduce the cost of industrial fermentation of arginine, our scientists have been working to develop inexpensive carbon sources that can be utilized by microbial strains for arginine production. Our work focuses on the development of renewable biological feedstocks for arginine production and the exploration of suitable mass ratios of carbon source mixes.
CD Biosynsis can develop tailored tools and customized approaches to harness the power of synthetic biology to drive arginine production and meet the needs of customers in a variety of industries.
CD Biosynsis provides the most comprehensive and efficient solutions for synthetic biology workflows. We are committed to helping our customers solve all problems encountered in arginine production to advance their applications in a wide range of fields. Each of our deliverables will undergo a rigorous quality inspection test to ensure the reliability and accuracy of the results. If you are interested in our services or have any further questions, please do not hesitate to contact us.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.